As a leader within the field of research of hair

Nourkrin® is committed to ensuring its recognition as a benchmark for excellence – not only by consumers, but also by scientists, dermatologists, cosmetologists and aestheticians worldwide.

Nourkrin® is based on more than 56 scientific studies and clinical papers published in leading peer-review journals.

Nourkrin® has been tested in placebo, double-blind studies and shown to be side effect free.* This is in contrast to other pharmaceuticals, which may cause; scalp itching, dryness, scaling, flaking, irritation, burning and in extreme instances weight gain, swelling of the face, ankles, hands or stomach, difficulty breathing (especially when lying down), rapid heartbeat, chest pain and light headedness.**

Nourkrin® continues to partner with the world’s leading authorities on hair loss and hair thinning based on its clinically documented efficacy and safety standards.

Nourkrin® contains naturally based ingredients that have been scientifically documented to be safe and effective.*

*Thom E. Nourkrin®: Objective and Subjective Effects and Tolerability in Persons with Hair Loss. J Int Med Res. 2006;34(5):514-9.
Publication: Link
Kingsley DH, Thom E. Cosmetic Hair Treatments Improve Quality of Life in Women with Female Pattern Hair Loss. J Appl Cosmetol. 2012;30:49-59.
Publication: Link
Thom E, Wadstein J, Thom EW, Kingsley DH. Treatment of Hair Thinning and Hair Ageing with Specific Lectican and Leucine Proteoglycans. A Review. J Appl Cosmetol. 2014;32:105-15.
Publication: Link
Thom E. Stress and the Hair Growth Cycle: Cortisol-Induced Hair Growth Disruption. J Drugs Dermatol. 2016;15(8):1001-4.
Publication: Link
Thom E. Pregnancy and the Hair Growth Cycle: Anagen Induction against Hair Growth Disruption using Nourkrin® with Marilex®, a Proteoglycan Replacement Therapy. J Cosmet Dermatol. 2017;16(3):421-7.
Publication: Link
Thom E, Thom EW. Lifestyle Diseases and the Hair Growth Cycle: A Multidisciplinary Approach using Nourkrin® with Marilex®, a Proteoglycan Replacement Therapy, for Anagen Induction and Maintenance. Ann Dermatol Res. 2017;1:6-11.
Publication: Link
Thom E, Wadstein J, Kingsley DH, Thom EW. Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing Hair Growth Disruptions using Nourkrin® with Marilex® as a Proteoglycan Replacement Therapy. A Concise Review. Ann Dermatol Res. 2018;2:1-7.
Publication: Link
**Studies about finastride: Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, et al. Finastride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol .1998;39:578-89 & Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol.1999;40;930-7.

Selected published clinical studies

'...a highly significant difference...in favour of the Nourkrin® treatment group'

2006 Clinical Study on the Nourkrin® effect and tolerability

Selected published clinical studies

'… utilizing a proteoglycan replacement therapy [Nourkrin®] to prevent postpartum hair loss will ultimately help long-term preservation of hair in women'

2016 Clinical Paper on postpartum hair loss

Selected published clinical studies

'It is beneficial using Nourkrin® as a continuous, baseline treatment...'

2012 Clinical Study on 100 females using Nourkrin®

Selected published clinical studies

'… Nourkrin® is recommended both as a prophylactic and a therapy, and especially in connection to stress-related hair loss …'

2016 Clinical Paper on stress-induced hair loss

Selected published clinical studies

'Nourkrin® with Marilex® has been shown to be an effective treatment for anagen induction and prolongation'

2018 CLINICAL PAPER ON LIFESTYLE DISEASES AND HAIR LOSS

Selected published clinical studies

'It is beneficial using Nourkrin® as a continuous, baseline treatment in all types of hair loss'

2014 Clinical Paper on treating hair thinning in women

Selected published clinical studies

'Nourkrin® with Marilex® has been shown to be an effective treatment for hair loss types associated with metabolic syndrome'

2018 CLINICAL PAPER ON METABOLIC SYNDROME, CARDIOVASCULAR DISEASE AND HAIR LOSS

SUBSCRIBE TO NOURKRIN® NEWS

Subscribe to our newsletter to stay up to date on the newest research within the field of hair growth disorders and female hair loss, information about upcoming events and competitions with Nourkrin®.